External reports (aggregated public sources), Value Investors Club

Value Investors Club (VIC)

External reports (aggregated public sources)

Value Investors Club

Equity Bottom-Up

<ul><li>Solventum (SOLV) is currently undervalued compared to its competitors, trading at only 7.4x EBITDA and 9.1x EPS</li><li>SOLV has strong financial metrics with high gross margins, operating margins, EBITDA margins, and ROE</li><li>The company operates in various growth industries such as wound care, oral care solutions, healthcare information systems, and water purification, presenting a rare opportunity for potential upside of +146% if it were to trade in line with its competitors</li></ul><p><em>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.</em></p>

Solventum (SOLV) is currently undervalued compared to its competitors, trading at only 7.4x EBITDA and 9.1x EPSSOLV has strong financial metrics with high gross margins, operating margins, EBITDA margins, and ROEThe company operates in various growth industries such as wound care, oral care solutions, healthcare information systems, and water purification, presenting a rare opportunity for potential upside of +146% if it were to trade in line with its competitorsThis content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Solventum Corp (SOLV) - Monday, Jun 3, 2024

United States

Solventum Corporation is a health care solutions company. The Company engages in developing, manufacturing, and commercialization a broad portfolio of solutions that leverages material and data science, clinical research, and digital capabilities. Solventum operates in separation and purification, health information, medical solutions, medical device component, and oral care market.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Solventum (SOLV US)

Solventum Corp (SOLV) - Monday, Jun 3, 2024

Solventum (SOLV) is currently undervalued compared to its competitors, trading at only 7.4x EBITDA and 9.1x EPS. SOLV has strong financial metrics...

Value Investors Club (VIC)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)